AI Labs Group S.L
8
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
29%
2 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity - Experts' Opinion
Role: lead
AI-based Medical Device Validation for Early Melanoma Detection
Role: lead
Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
Role: lead
Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
Role: lead
Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
Role: lead
Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care
Role: lead
Pilot Study: AI Algorithm for Dermatology Referral Optimization
Role: lead
Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
Role: lead
All 8 trials loaded